Viroclinics-DDL rebrands to Cerba Research

Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands) a world leading vaccine and antiviral specialty laboratory providing research and clinical trial solutions rooted in virology, proudly announces changing its name to Cerba Research as of the 1st of April 2024.

Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC

Adding immunotherapy to chemoradiation therapy (CRT) for limited-stage small cell lung cancer (SCLC) failed to improve survival in a randomized trial. As compared with CRT

October 3, 2024

What’s in a drink? U.S. regulators consider new alcohol label, but health advocates want even more

If you twirl a bottle of alcohol and squint, you might see a text box with a warning. Usually in black and white, with letters

August 12, 2024

ASCO’s Quality Care Symposium: Chemotherapy Shortage Resulted in Higher Costs

Studies presented at the upcoming American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco will look at the impact of the 2023

September 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.